US Bancorp
ASMB icon

US Bancorp’s Assembly Biosciences ASMB Stock Holding History

US Bancorp’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-59
Closed -$1.64K – 4169
2026
Q1 		$1.64K Hold
59
– – ﹤0.01% 3847
2025
Q4 		$2.01K Buy
+59
New +$1.9K ﹤0.01% 3754
2021
Q1 		– Sell
-13
Closed -$1K – 3872
2020
Q4 		$1K Hold
13
– – ﹤0.01% 3641
2020
Q3 		$3K Hold
13
– – ﹤0.01% 3395
2020
Q2 		$4K Buy
+13
New +$3.03K ﹤0.01% 3357
2018
Q4 		– Sell
-17
Closed -$7K – 3582
2018
Q3 		$7K Buy
+17
New +$7.96K ﹤0.01% 3227

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

US Bancorp's ASMB Position: Q2 2026 in Review

US Bancorp sold out of Assembly Biosciences (ASMB) in Q2 2026, closing a stake of 59 shares — an estimated $1.64K sold.

US Bancorp first reported a position in ASMB in Q3 2018 and held it in 6 quarters. The position peaked at $7K in Q3 2018. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • US Bancorp reported no remaining Assembly Biosciences position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 59 Assembly Biosciences shares in Q2 2026, an estimated $1.64K.
  • US Bancorp first reported a position in Assembly Biosciences in Q3 2018 and held it in 6 quarters.
  • US Bancorp's Assembly Biosciences position peaked at $7K in Q3 2018.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.